You are here

Tofacitinib Ointment For Chronic Plaque Psoriasis

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Burke Pharmaceutical Research
Hot Springs, Arkansas, 71913 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis Vulgaris, Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Have mild, moderate or severe plaque psoriasis (psoriasis vulgaris) for at least 6
months prior to Baseline

- At Baseline, have plaque psoriasis covering 2% to 20% of total body surface area (BSA)
on the trunk and limbs (excluding palms, soles, and nails)

- If received certain treatments, should be off treatment for a minimum period of time
(washout)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Currently have non-plaque forms of psoriasis or drug-induced psoriasis

- Require treatment with or cannot stop medication(s) prohibited during the study

- Have certain laboratory abnormalities at Baseline

- Current or history of certain infections

- Females who are pregnant, breastfeeding, or are of childbearing potential not using
highly effective contraception

NCT01831466
Pfizer
Completed
Tofacitinib Ointment For Chronic Plaque Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now